Cancer

Items 21-30 of 33

per page
Set Descending Direction
  1. anti-Nampt (Visfatin/PBEF), mAb (OMNI379)
    AG-20A-0034
    AG-20A-0034-C05050 µg
    CHF 290.00
    AG-20A-0034-C100100 µg
    CHF 410.00
    Immunoprecipitation of recombinant human Nampt(Visfatin/PBEF) proteins using anti-Nampt (Visfatin-PBEF), mAb (OMNI379) (Prod. No. AG-20A-0034). Recombinant human Nampt(Visfatin/PBEF) proteins at different concentrations were precipitated. The precipitated
  2. anti-Nampt (Visfatin/PBEF), mAb (OMNI379) (Biotin)
    AG-20A-0034B
    AG-20A-0034B-C05050 µg
    CHF 350.00
    Immunohistochemical staining of Nampt using anti-Nampt (Visfatin/PBEF), mAb (OMNI379) (Prod. No. AG-20A-0034B) in formalin-fixed and paraffin-embedded (FFPE) human colon tissue (15µg/ml).
  3. anti-PARP-1 [ARTD1] (human), pAb
    AG-25T-0002
    AG-25T-0002-R100100 µl
    CHF 280.00
  4. anti-PARP-1 [ARTD1] (mouse), pAb
    AG-25T-0001
    AG-25T-0001-R100100 µl
    CHF 340.00
  5. anti-PARP-2 [ARTD2] (mouse), pAb
    AG-25T-0003
    AG-25T-0003-R100100 µl
    CHF 350.00
  6. anti-Phospho-GSK-3beta (Ser9), Rabbit Monoclonal (RM453)
    REV-31-1345-00
    REV-31-1345-00-R100100 µl
    CHF 459.00
    anti-Phospho-GSK-3beta (Ser9), Rabbit Monoclonal (RM453)
  7. anti-Phospho-JNK1/2/3 (Thr183/Tyr185), Rabbit Monoclonal (RM464)
    REV-31-1356-00
    REV-31-1356-00-R100100 µl
    CHF 459.00
    anti-Phospho-JNK1/2/3 (Thr183/Tyr185), Rabbit Monoclonal (RM464)
  8. anti-Phospho-Rsk1 (Thr359/Ser363) (human), Rabbit Monoclonal (RM233)
    REV-31-1117-00
    REV-31-1117-00-R100100 µl
    CHF 459.00
    Immunohistochemical staining of formalin fixed and paraffin embedded human cerebral cortex tissue sections using Anti-phospho-Rsk1 (Thr359/Ser363) RM233 at a 1:200 dilution.
  9. anti-Phospho-Tau (Ser396), Rabbit Monoclonal (RM461)
    REV-31-1353-00
    REV-31-1353-00-R100100 µl
    CHF 459.00
    anti-Phospho-Tau (Ser396), Rabbit Monoclonal (RM461)

Items 21-30 of 33

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.